These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16825504)

  • 1. A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin.
    Talantov D; Baden J; Jatkoe T; Hahn K; Yu J; Rajpurohit Y; Jiang Y; Choi C; Ross JS; Atkins D; Wang Y; Mazumder A
    J Mol Diagn; 2006 Jul; 8(3):320-9. PubMed ID: 16825504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient identification of miRNAs for classification of tumor origin.
    Søkilde R; Vincent M; Møller AK; Hansen A; Høiby PE; Blondal T; Nielsen BS; Daugaard G; Møller S; Litman T
    J Mol Diagn; 2014 Jan; 16(1):106-15. PubMed ID: 24211363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin.
    Tothill RW; Kowalczyk A; Rischin D; Bousioutas A; Haviv I; van Laar RK; Waring PM; Zalcberg J; Ward R; Biankin AV; Sutherland RL; Henshall SM; Fong K; Pollack JR; Bowtell DD; Holloway AJ
    Cancer Res; 2005 May; 65(10):4031-40. PubMed ID: 15899792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RT-PCR-based gene expression profiling for cancer biomarker discovery from fixed, paraffin-embedded tissues.
    Scott A; Ambannavar R; Jeong J; Liu ML; Cronin MT
    Methods Mol Biol; 2011; 724():239-57. PubMed ID: 21370017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.
    Varadhachary GR; Talantov D; Raber MN; Meng C; Hess KR; Jatkoe T; Lenzi R; Spigel DR; Wang Y; Greco FA; Abbruzzese JL; Hainsworth JD
    J Clin Oncol; 2008 Sep; 26(27):4442-8. PubMed ID: 18802157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnosis of Ewing sarcoma family of tumors: a comparative analysis of 560 cases with FISH and RT-PCR.
    Machado I; Noguera R; Pellin A; Lopez-Guerrero JA; Piqueras M; Navarro S; Llombart-Bosch A
    Diagn Mol Pathol; 2009 Dec; 18(4):189-99. PubMed ID: 19861898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Illumina whole-genome complementary DNA-mediated annealing, selection, extension and ligation platform: assessing its performance in formalin-fixed, paraffin-embedded samples and identifying invasion pattern-related genes in oral squamous cell carcinoma.
    Loudig O; Brandwein-Gensler M; Kim RS; Lin J; Isayeva T; Liu C; Segall JE; Kenny PA; Prystowsky MB
    Hum Pathol; 2011 Dec; 42(12):1911-22. PubMed ID: 21683979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the site of origin of tumors by a gene expression signature derived from normal tissues.
    Staub E; Buhr HJ; Gröne J
    Oncogene; 2010 Aug; 29(31):4485-92. PubMed ID: 20514016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of duration of fixation on quantitative reverse transcription polymerase chain reaction analyses.
    Macabeo-Ong M; Ginzinger DG; Dekker N; McMillan A; Regezi JA; Wong DT; Jordan RC
    Mod Pathol; 2002 Sep; 15(9):979-87. PubMed ID: 12218216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multisite validation study to determine performance characteristics of a 92-gene molecular cancer classifier.
    Kerr SE; Schnabel CA; Sullivan PS; Zhang Y; Singh V; Carey B; Erlander MG; Highsmith WE; Dry SM; Brachtel EF
    Clin Cancer Res; 2012 Jul; 18(14):3952-60. PubMed ID: 22648269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of putative reference genes for normalization of Q-RT-PCR data from paraffin-embedded lymphoid tissue.
    Green TM; de Stricker K; Møller MB
    Diagn Mol Pathol; 2009 Dec; 18(4):243-9. PubMed ID: 19861891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression analysis in biomarker research and early drug development using function tested reverse transcription quantitative real-time PCR assays.
    Lohmann S; Herold A; Bergauer T; Belousov A; Betzl G; Demario M; Dietrich M; Luistro L; Poignée-Heger M; Schostack K; Simcox M; Walch H; Yin X; Zhong H; Weisser M
    Methods; 2013 Jan; 59(1):10-9. PubMed ID: 22796720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
    Kosari F; Parker AS; Kube DM; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Vasmatzis G
    Clin Cancer Res; 2005 Jul; 11(14):5128-39. PubMed ID: 16033827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay.
    Ma XJ; Patel R; Wang X; Salunga R; Murage J; Desai R; Tuggle JT; Wang W; Chu S; Stecker K; Raja R; Robin H; Moore M; Baunoch D; Sgroi D; Erlander M
    Arch Pathol Lab Med; 2006 Apr; 130(4):465-73. PubMed ID: 16594740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
    Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
    Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression of vascular endothelial growth factor A, thymidylate synthase, and tissue inhibitor of metalloproteinase 3 in prediction of response to bevacizumab treatment in colorectal cancer patients.
    Watanabe T; Kobunai T; Yamamoto Y; Matsuda K; Ishihara S; Nozawa K; Iinuma H; Ikeuchi H
    Dis Colon Rectum; 2011 Aug; 54(8):1026-35. PubMed ID: 21730794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of tissue of origin in body fluid specimens using a gene expression microarray assay.
    Stancel GA; Coffey D; Alvarez K; Halks-Miller M; Lal A; Mody D; Koen T; Fairley T; Monzon FA
    Cancer Cytopathol; 2012 Feb; 120(1):62-70. PubMed ID: 21717591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
    Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
    Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
    Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.